Sanofi Ventures is the corporate venture arm of Sanofi, the global pharmaceutical company. It invests in early-stage biotech and digital health companies aligned with Sanofi's strategic therapeutic interests, which include immunology, oncology, rare diseases, and neurology.

Sanofi Ventures has invested in Therini Bio (neuroinflammation/Alzheimer's immunotherapy), reflecting active interest in neurodegeneration and brain health therapeutics. The fund provides capital alongside strategic value through Sanofi's clinical, regulatory, and commercial infrastructure. Most relevant for neurotech companies with CNS therapeutic approaches that could complement or partner with pharmaceutical development.